Table 2. Prevalence of EBV, HPV, CMV and HSV by sex, age, place of residence and duration of diabetes.
| EBV | HPV | CMV | HSV | EBV+HPV | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| N | % | N | % | N | % | N | % | N | % | |
| Sex | ||||||||||
| Male | 17 | 32.7 | 10 | 19.2 | 5 | 9.6 | 4 | 7.7 | 16 | 30.8 |
| Female | 27 | 38.0 | 23 | 32.4 | 4 | 5.6 | 14 | 19.7 | 3 | 4.2 |
| p | 0.5419 | 0.1035 | 0.4022 | 0.0623 | 0.0004* | |||||
| Age | ||||||||||
| 20–39 | 5 | 11.4 | 3 | 9.1 | 1 | 11.1 | 4 | 22.2 | 4 | 21.1 |
| 40–59 | 17 | 38.6 | 12 | 36.4 | 2 | 22.2 | 4 | 22.2 | 10 | 52.6 |
| 60+ | 22 | 50.0 | 18 | 54.5 | 6 | 66.7 | 10 | 55.6 | 5 | 26.3 |
| p | 0.7159 | 0.4191 | 0.4341 | 0.1917 | 0.0512 | |||||
| Place of residence | ||||||||||
| Urban | 22 | 26.8 | 16 | 91.5 | 6 | 7.3 | 12 | 14.6 | 16 | 22.2 |
| Rural | 22 | 53.7 | 17 | 41.6 | 3 | 7.3 | 6 | 14.6 | 3 | 5.9 |
| p | 0.0034* | 0.0034* | 0.9999 | 0.9999 | 0.0351* | |||||
| Duration of diabetes (years) | ||||||||||
| 1–5 | 13 | 29.5 | 3 | 9.1 | 0 | 0 | 5 | 27.8 | 1 | 5.3 |
| 6–10 | 9 | 20.0 | 9 | 27.3 | 2 | 22.2 | 6 | 33.3 | 2 | 10.5 |
| >10 | 22 | 50.0 | 21 | 63.6 | 7 | 77.8 | 7 | 38.9 | 16 | 84.2 |
| p | 0.00004* | 10−6* | 0.0349* | 0.4963 | 0.0376* | |||||
*statistically significant (Pearson’s chi-square test)
EBV–Epstein-Barr Virus, HPV–Human Papillomavirus, CMV–Cytomegalovirus, HSV—Herpes Simplex Virus